Get started
Author

Francisco Muñoz Beamud

Observed names: F. Beamud, Francisco Munoz Beamud
OpenAlex ID: A5067938048
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain
2020 · Juan Berenguer, Juan Berenguer, et al. · Clinical Microbiology and Infection · 401
PDF
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study
2020 · David Adams, Michael Polydefkis, et al. · The Lancet Neurology · 159
Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)
2020 · Jesús Rodríguez-Baño, Jerónimo Pachón, et al. · Clinical Microbiology and Infection · 122
Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year update
2022 · Angela Dispenzieri, Teresa Coelho, et al. · Orphanet Journal of Rare Diseases · 87
Sex-Related Risk of Cardiac Involvement in Hereditary Transthyretin Amyloidosis
2021 · Angelo Giuseppe Caponetti, Claudio Rapezzi, et al. · JACC Heart Failure · 79
Characteristics of Patients with Late- vs. Early-Onset Val30Met Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)
2021 · Márcia Waddington-Cruz, Jonas Wixner, et al. · Neurology and Therapy · 48
PDF
Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy
2025 · David Adams, Jonas Wixner, et al. · JAMA Neurology · 40
PDF
Clinical and Genotype Characteristics and Symptom Migration in Patients With Mixed Phenotype Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey
2023 · Juan González-Moreno, Angela Dispenzieri, et al. · Cardiology and Therapy · 25
Survival in a Contemporary, Real-World Cohort of Patients with Mixed-Phenotype Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis: An Analysis from THAOS
2025 · Jonas Wixner, Angela Dispenzieri, et al. · Cardiology and Therapy · 9
PDF
A description of variant transthyretin amyloidosis (ATTRv) stage 1 patients and asymptomatic carriers in Spain: the EMPATIa study
2024 · Lucía Galán Dávila, Fernando Martinez Valle, et al. · Orphanet Journal of Rare Diseases · 5
PDF
Clinical utility of neurofilament light chain as a biomarker for disease onset and progression in hereditary transthyretin amyloidosis
2025 · Álvaro Gragera-Martínez, Cristina Borrachero Garro, et al. · Frontiers in Neurology · 4
PDF
Mortality reduction in older COVID-19-patients hospitalized in Spain during the second pandemic wave from the SEMI-COVID-19 Registry
2023 · José-Manuel Casas-Rojo, Juan-Miguel Antón-Santos, et al. · Scientific Reports · 3
PDF
Validation of the RIM Score-COVID in the Spanish SEMI-COVID-19 Registry
2023 · José-Manuel Ramos-Rincón, Paula Sol Ventura, et al. · Internal and Emergency Medicine · 2
PDF
Economic and healthcare resource utilization for hereditary transthyretin amyloidosis with polyneuropathy in Spain: real-world insights from early-stage patients and mutation carriers
2025 · Fernando Martínez Valle, Lucía Galán Dávila, et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 1
PDF
Management of Hereditary Transthyretin Amyloidosis (ATTRv) Patients and Asymptomatic Carriers in Spain: The EMPATIa Study
2024 · Inés Losada López, Juan Gonzalez-Moreno, et al. · Journal of Clinical Medicine · 1
PDF
Impact of SARS-CoV-2 infection therapies on the risk of venous thromboembolism and cardiovascular events from the SEMI-COVID-19 Registry
2025 · Crhistian-Mario Oblitas, Pablo Demelo-Rodríguez, et al. · Scientific Reports
THU0399 Systemic Amyloidosis as A Multi-Organ, Life-Threatening Disease: Predictive Baseline Factors Associated to Mortality in 570 Patients (Ramyd-Geas-Semi Registry)
2014 · P. Brito Zeron, L.E. Cajamarca, et al. · Annals of the Rheumatic Diseases
P0100 Management of High Risk Gestation in Patients With Autoimmune Disorders and Hypercoagulable States
2009 · Carmen Manzano Badia, Francisco Muñoz Beamud, et al. · European Journal of Internal Medicine
Works count: 18
Citation count: 985
H-index: 9
I10-index: 8
Year
Topic
Type